Radiation Safety Considerations for the Use of 223RaCl2 DE in Men with Castration-resistant Prostate Cancer-Reference-Cited by-同舟云学术

Radiation Safety Considerations for the Use of 223RaCl2 DE in Men with Castration-resistant Prostate Cancer

Published:2014-04 Issue:4 Volume:106 Page:494-504
ISSN:0017-9078
Container-title:Health Physics
language:en
Short-container-title:

Author:

Dauer Lawrence T.,Williamson Matthew J.,Humm John,O’Donoghue Joseph,Ghani Rashid,Awadallah Robert,Carrasquillo Jorge,Pandit-Taskar Neeta,Aksnes Anne-Kirsti,Biggin Colin,Reinton Vigdis,Morris Michael,St. Germain Jean

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Health, Toxicology and Mutagenesis,Radiology, Nuclear Medicine and imaging,Epidemiology

Reference34 articles.

1. A multiinstitutional, concurrent chemoradiation trial of strontium-89, estramustine, and vinblastine for hormone refractory prostate carcinoma involving bone.;Akerley;Cancer,2002

2. Bone-targeted therapy: phase II study of strontium-89 in combination with alternating weekly chemohormonal therapies for patients with advanced androgen-independent prostate cancer.;Amato;Am J Clin Oncol,2008

3. Therapeutic strategies for bone metastases and their clinical sequelae in prostate cancer.;Autio;Curr Treat Options Oncol,2012

4. Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.;Bauman;Radiother Oncol,2005

5. High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities Clin Cancer R;Bruland;es,2006

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to 223RaCl2 or 177Lu-iPSMA treatment in bone metastases due to castration-resistant prostate cancer as a function of absorbed dose;Radiation Physics and Chemistry;2024-09

2. Targeted Radiopharmaceutical Therapy for Bone Metastases;Seminars in Nuclear Medicine;2024-07

3. Alpha-Emitting Radionuclides: Current Status and Future Perspectives;Pharmaceuticals;2024-01-08

4. Advances in Radiotherapy Dosimetry Techniques and Pre-Treatment Verification;Dosimetry and Radiopharmaceuticals - New Advances and Needs [Working Title];2023-11-07

5. SNMMI Procedure Standard/EANM Practice Guideline for Palliative Nuclear Medicine Therapies of Bone Metastases;Journal of Nuclear Medicine Technology;2023-06-14